Published in Blood Weekly, May 4th, 2000
A. Raza, of the Rush Cancer Institute, Illinois, and colleagues studied 35 MDS patients registered on protocol MDS 96-02. The patients were orally administered 800 mg of pentoxifylline three times a day and 500 mg of ciprofloxacin twice a day. After 12 weeks of therapy, patients who did not fully respond to this treatment were additionally treated with 4 mg of dexamethasone, taken orally each morning for four weeks.
Three groups, each consisting of 10 patients, received intravenous...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.